Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot suit aims to help stroke and spinal injury patients walk again

NCT ID NCT06805500

Knowledge-focused Sponsor: Roessingh Research and Development Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new robotic device called REACTION that combines an exoskeleton and a gait trainer to help people with stroke or spinal cord injury improve walking and balance. Seven participants completed two sessions of walking and balance tasks, followed by an interview. The goal was to see if the device is feasible and to measure walking speed and balance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
REACTION device (combination of exoskeleton and gait trainer)
What this could lead to
If successful, this could lead to a new rehabilitation tool that helps improve walking and balance in people with neurological conditions.
What could go wrong
This is a very small feasibility study with only 7 participants, so results may not apply to everyone. The device is still in early testing and may not improve walking speed significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

7 people

The number who actually took part.

Started

May 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

In order to be eligible to participate in this study, a participant must meet all of the following criteria: * Age \> 16 years * Able to give informed consent Stroke patients: * first-ever ischemic or haemorrhagic stroke * FAC score between 3 and 4 * (Sub)acute or chronic phase SCI patients: * Neurological injury levels ranging from C5 to T9 * Motor incomplete spinal cord injury (ASIA impairment score of C or D) * Able to walk independently (without physical support) Exclusion Criteria: A potential participant who meets any of the following criteria will be excluded from participation in this study: * Premorbid disability of lower extremity * Progressive neurological diseases like dementia or Parkinson * Skin lesions or severely impaired sensation at the hemiparetic leg * Contraindication for mobilization, like lower limb fracture * Insufficient knowledge of the Dutch language to understand the purpose or meth-ods of the study * Pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spinal cord injury are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

nervous system disorder spinal cord injury stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Spinal cord injury Stroke

Contacts and locations

Locations

  • Roessingh Research and Development

    Enschede, Netherlands

  • Sint Maartenskliniek

    Ubbergen, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.